This inventor holds 1 USPTO granted patent. Top assignees: Centre National De La Recherche Scientifique, Ecole Normale Superieure De Lyon, National Institute of Health and Medical Research. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5,384 
1 out of 44 
1 out of 1,853 
Years Active: 2022
Title: Marie-Helene Cavanagh: Innovator in Vaccine Development
Introduction
Marie-Helene Cavanagh is a notable inventor based in Levis, Canada. She has made significant contributions to the field of virology, particularly in the development of vaccines. Her work has implications for public health and disease prevention.
Latest Patents
Cavanagh holds a patent for an attenuated virus strain and its use as a vaccine. This invention relates to a strain derived from a human metapneumovirus, which includes genetic modifications that reduce its virulence. The patent is a crucial step in advancing vaccine technology.
Career Highlights
Throughout her career, Cavanagh has worked with prestigious institutions such as Université Claude Bernard Lyon 1 and the Centre National de la Recherche Scientifique. Her research has focused on understanding viral mechanisms and developing effective vaccines.
Collaborations
Cavanagh has collaborated with esteemed colleagues, including Manuel Rosa-Calatrava and Guy Boivin. These partnerships have enhanced her research and contributed to the advancement of vaccine development.
Conclusion
Marie-Helene Cavanagh's innovative work in vaccine development highlights her importance in the field of virology. Her contributions continue to impact public health and pave the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile